108 related articles for article (PubMed ID: 1917161)
1. Dipyridamole enhancement of doxorubicin-induced translocation of nucleophosmin and inhibition of cell growth in HL-60 cells.
Yung BY; Chang FJ; Luo KJ
Int J Cancer; 1991 Oct; 49(4):592-7. PubMed ID: 1917161
[TBL] [Abstract][Full Text] [Related]
2. Phosphoprotein B23 translocation and modulation of actinomycin D and doxorubicin cytotoxicity by dipyridamole in HeLa cells.
Bor AM; Chang FJ; Yung BY
Int J Cancer; 1992 Oct; 52(4):658-63. PubMed ID: 1399149
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole.
Howell SB; Hom D; Sanga R; Vick JS; Abramson IS
Cancer Res; 1989 Jun; 49(12):3178-83. PubMed ID: 2720673
[TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent sphinganine potentiation of retinoic acid-induced differentiation, cell growth inhibition, and nucleophosmin translocation in a human leukemia cell line (HL-60).
Hui EK; Yang YH; Yung BY
Exp Hematol; 1992 May; 20(4):454-61. PubMed ID: 1568462
[TBL] [Abstract][Full Text] [Related]
5. Identification of high-density lipoprotein in serum to determine anti-cancer efficacy of doxorubicin in HeLa cells.
Yung BY; Bor AM
Int J Cancer; 1992 Apr; 50(6):951-7. PubMed ID: 1555894
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line.
Yung BY; Yang YH; Bor AM
Int J Cancer; 1991 Jul; 48(5):779-84. PubMed ID: 2071236
[TBL] [Abstract][Full Text] [Related]
7. Dipyridamole enhancement of drug sensitivity in acute lymphoblastic leukemia cells.
Sotomatsu M; Yugami S; Shitara T; Kuroume T
Am J Hematol; 1993 Aug; 43(4):251-5. PubMed ID: 8372807
[TBL] [Abstract][Full Text] [Related]
8. Characterization and cellular localization of nucleophosmin/B23 in HeLa cells treated with selected cytotoxic agents (studies of B23-translocation mechanism).
Chan PK
Exp Cell Res; 1992 Nov; 203(1):174-81. PubMed ID: 1426041
[TBL] [Abstract][Full Text] [Related]
9. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
Liu WH; Yung BY
Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar localization of nucleophosmin/B23 requires GTP.
Finch RA; Revankar GR; Chan PK
J Biol Chem; 1993 Mar; 268(8):5823-7. PubMed ID: 8095498
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.
Hsu CY; Yung BY
Oncogene; 1998 Feb; 16(7):915-23. PubMed ID: 9484783
[TBL] [Abstract][Full Text] [Related]
12. Methyl-beta-cyclodextrin in HL-60 parental and multidrug-resistant cancer cell lines: effect on the cytotoxic activity and intracellular accumulation of doxorubicin.
Grosse PY; Bressolle F; Pinguet F
Cancer Chemother Pharmacol; 1997; 40(6):489-94. PubMed ID: 9332463
[TBL] [Abstract][Full Text] [Related]
13. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
Yung BY; Bor AM; Chan PK
Cancer Res; 1990 Sep; 50(18):5987-91. PubMed ID: 1697505
[TBL] [Abstract][Full Text] [Related]
14. Translocation of nucleophosmin from nucleoli to nucleoplasm requires ATP.
Wu MH; Lam CY; Yung BY
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):987-92. PubMed ID: 7848301
[TBL] [Abstract][Full Text] [Related]
15. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity.
Wu HL; Hsu CY; Liu WH; Yung BY
Int J Cancer; 1999 Jun; 81(6):923-9. PubMed ID: 10362140
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of phosphoprotein B23 in proliferating and non-proliferating HeLa cells.
Yung BY; Bor AM; Yang YH
Int J Cancer; 1990 Aug; 46(2):272-5. PubMed ID: 2200756
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole enhancement of etoposide sensitivity.
Howell SB; Hom DK; Sanga R; Vick JS; Chan TC
Cancer Res; 1989 Aug; 49(15):4147-53. PubMed ID: 2545335
[TBL] [Abstract][Full Text] [Related]
18. Nucleophosmin/B23 regulates the susceptibility of human leukemia HL-60 cells to sodium butyrate-induced apoptosis and inhibition of telomerase activity.
Liu WH; Hsu CY; Yung BY
Int J Cancer; 1999 Dec; 83(6):765-71. PubMed ID: 10597193
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle phase-dependent changes of localization and oligomerization states of nucleophosmin / B23.
Chou YH; Yung BY
Biochem Biophys Res Commun; 1995 Dec; 217(1):313-25. PubMed ID: 8526928
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
